Friday, August 30, 2019 1:29:36 PM
DISTINCTION BETWEEN BLP AND NNVC
You hit the nail on the head Nanotoday. In the case of BLP, the scientific basis of their claim is as they say "worse than wrong". All of quantum physics and all the investions we use today that would only work if the essence of quantum mechanics (QM) were right would have to be wrong for BLP's "hydrino hype( below ground state hydrogen atom) to be true. So we know that BLP can only sell its story to those who don't understand the ABC s of QM.
In the NNVC case there is no sceintific reason why the basis of a nanoviricide can't possbiliy work. In fact a research group at MIT has shown that the conceptual basis of a nanoviricide is essentially correct. NNVC's probem and the basis of a law suit is that they have never gotten it to be commercially feasible but their statments to investors have presented a diffent picture - a picture of progress towards that goal.
BLP has lied about the science while NNVC has lied about its progress to commercialize a valid idea. It turns out that proving the latter will be easier than proving the former.
Trendliner
You hit the nail on the head Nanotoday. In the case of BLP, the scientific basis of their claim is as they say "worse than wrong". All of quantum physics and all the investions we use today that would only work if the essence of quantum mechanics (QM) were right would have to be wrong for BLP's "hydrino hype( below ground state hydrogen atom) to be true. So we know that BLP can only sell its story to those who don't understand the ABC s of QM.
In the NNVC case there is no sceintific reason why the basis of a nanoviricide can't possbiliy work. In fact a research group at MIT has shown that the conceptual basis of a nanoviricide is essentially correct. NNVC's probem and the basis of a law suit is that they have never gotten it to be commercially feasible but their statments to investors have presented a diffent picture - a picture of progress towards that goal.
BLP has lied about the science while NNVC has lied about its progress to commercialize a valid idea. It turns out that proving the latter will be easier than proving the former.
Trendliner
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
